Publications

Publications

Harding, C. M.;  Nasr, M. A.;  Scott, N. E.;  Goyette-Desjardins, G.;  Nothaft, H.;  Mayer, A. E.;  Chavez, S. M.;  Huynh, J. P.;  Kinsella, R. L.;  Szymanski, C. M.;  Stallings, C. L.;  Segura, M.; Feldman, M. F., A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host. Nat Commun 2019, 10 (1), 891.

Harding, C. M.; Feldman, M. F., Glycoengineering bioconjugate vaccines, therapeutics, and diagnostics in E. coli. Glycobiology 2019, 29 (7), 519-529.

Feldman, M. F.;  Mayer Bridwell, A. E.;  Scott, N. E.;  Vinogradov, E.;  McKee, S. R.;  Chavez, S. M.;  Twentyman, J.;  Stallings, C. L.;  Rosen, D. A.; Harding, C. M., A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae. Proc Natl Acad Sci U S A 2019, 116 (37), 18655-18663.

Knoot, C. J.;  Robinson, L. S.; Harding, C. M., A minimal sequon sufficient for O-linked glycosylation by the versatile oligosaccharyltransferase PglS. Glycobiology 2021, 31 (9), 1192-1203.

Duke, J. A.;  Paschall, A. V.;  Robinson, L. S.;  Knoot, C. J.;  Vinogradov, E.;  Scott, N. E.;  Feldman, M. F.;  Avci, F. Y.; Harding, C. M., Development and Immunogenicity of a Prototype Multivalent Group B Streptococcus Bioconjugate Vaccine. ACS Infect Dis 2021, 7 (11), 3111-3123.